Literature DB >> 15564723

The biochemistry and biology of BAFF, APRIL and their receptors.

Susan L Kalled1, Christine Ambrose, Yen-Ming Hsu.   

Abstract

The tumor necrosis factor (TNF) family of related receptors and ligands contains a rich collection of molecules that are important players in a broad spectrum of biological systems. While several family members are critical for development and function of the immune system, providing both activation and death signals, other members are involved in nonimmunological functions as diverse as hair follicle formation. TNF homology searches during the past several years have led to the discovery of numerous novel ligands, two of which will be the focus of this review. BAFF, a cytokine responsible for B cell survival, has recently been the subject of intense investigation that has expanded our understanding of mature B cell genesis, and mechanisms involved in developing B cell pathologies. APRIL is a close relative of BAFF and while its biological roles are less well understood, it may have both immune and non-immune functions. Herein we will discuss the discovery, structure, cognate receptors and functions of these two proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15564723     DOI: 10.1159/000082105

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  15 in total

Review 1.  A conspicuous role for B cells In Sjögren's syndrome.

Authors:  Pierre Youinou; Valérie Devauchelle; Pascal Hutin; Rozenn Le Berre; Alain Saraux; Jacques-Olivier Pers
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

2.  BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.

Authors:  Jean L Scholz; Jenni E Crowley; Mary M Tomayko; Natalie Steinel; Patrick J O'Neill; William J Quinn; Radhika Goenka; Juli P Miller; Yun Hee Cho; Vatana Long; Chris Ward; Thi-Sau Migone; Mark J Shlomchik; Michael P Cancro
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

Review 3.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

4.  Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.

Authors:  Irina Debnath; Kirstin M Roundy; Janis J Weis; John H Weis
Journal:  Mol Immunol       Date:  2006-11-30       Impact factor: 4.407

5.  High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia.

Authors:  Xiao-juan Zhu; Yan Shi; Jian-zhi Sun; Ning-ning Shan; Jun Peng; Cheng-shan Guo; Ping Qin; Ming Hou
Journal:  J Clin Immunol       Date:  2009-06-05       Impact factor: 8.317

Review 6.  Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles.

Authors:  Frédéric Coutant; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2016-09-22       Impact factor: 20.543

7.  APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa.

Authors:  Bertrand Huard; Thomas McKee; Carine Bosshard; Stéphane Durual; Thomas Matthes; Samir Myit; Olivier Donze; Christophe Frossard; Carlo Chizzolini; Christiane Favre; Rudolf Zubler; Jean Philippe Guyot; Pascal Schneider; Eddy Roosnek
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 8.  The BLyS family: toward a molecular understanding of B cell homeostasis.

Authors:  John F Treml; Yi Hao; Jason E Stadanlick; Michael P Cancro
Journal:  Cell Biochem Biophys       Date:  2008-11-26       Impact factor: 2.194

9.  B-cell-activating factor and autoimmune myasthenia gravis.

Authors:  Samia Ragheb; Robert P Lisak
Journal:  Autoimmune Dis       Date:  2011-11-28

10.  BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer.

Authors:  Laëtitia Le Pottier; Boutahar Bendaoud; Maryvonne Dueymes; Capucine Daridon; Pierre Youinou; Yehuda Shoenfeld; Jacques-Olivier Pers
Journal:  J Clin Immunol       Date:  2007-03-29       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.